MICA and cancer: Infusions of activated NK cells can scavenge circulating soluble MICA in cancer patients, leading to reinstate NKG2D-mediated immune surveillance.235 Although our understanding of the control of NKG2D ligand expression remains limited, research in recent years revealed various cellular mechanisms by which cancer cells evaded detection by reducing the “stress-induced ligands” expression.